Skip to main content
. Author manuscript; available in PMC: 2021 Jul 15.
Published in final edited form as: Vaccine. 2020 Mar 17;38(18):3411–3421. doi: 10.1016/j.vaccine.2020.03.014

Fig. 4.

Fig. 4

Reverse cumulative distributions of anti-CS (A), anti-HBs (B), anti-measles (C), anti-rubella (D), anti-YF (E) antibodies at 1 month after the third dose of RTS,S/AS01 vaccine (RTS,S coad and RTS,S alone groups) and at 1 month after the MR and YF vaccination (RTS,S coad and Control groups) - per-protocol set. The RTS,S coad group received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age and the YF and MR vaccines at 9 months of age; the RTS,S alone group received the RTS,S/AS01 vaccines at 6, 7.5 and 9 months of age; and the Control group received the YF and MR vaccines at 9 months of age. CS, circumsporozoite; HBs, hepatitis B surface antigens; YF, yellow fever; MR, combined measles-rubella. (For interpretation of the references to colour in this figure legend, the reader is referred to the web version of this article.)